Truncation of the last six amino acids in Dynorphin A leads to this undecapeptide which exhibited nearly the same selectivity and activity compared to the parent compound. Therefore, Dyn A (1-11)-amide has been widely used for structure-activity studies.
编号：190790
CAS号：79985-48-1
单字母：H2N-YGGFLRRIRPK-NH2
| 编号: | 190790 |
| 中文名称: | 强啡肽A(1-11)酰胺化、Dynorphin A(1-11)amide |
| 英文名: | Dynorphin A(1-11)amide |
| CAS号: | 79985-48-1 |
| 单字母: | H2N-YGGFLRRIRPK-NH2 |
| 三字母: | H2N N端氨基 -Tyr酪氨酸 -Gly甘氨酸 -Gly甘氨酸 -Phe苯丙氨酸 -Leu亮氨酸 -Arg精氨酸 -Arg精氨酸 -Ile异亮氨酸 -Arg精氨酸 -Pro脯氨酸 -Lys赖氨酸 -NH2C端酰胺化 |
| 氨基酸个数: | 11 |
| 分子式: | C63H104N22O12 |
| 平均分子量: | 1361.64 |
| 精确分子量: | 1360.82 |
| 等电点(PI): | - |
| pH=7.0时的净电荷数: | 5.97 |
| 平均亲水性: | 0.3125 |
| 疏水性值: | -0.87 |
| 外观与性状: | 白色粉末状固体 |
| 消光系数: | 1490 |
| 来源: | 人工化学合成，仅限科学研究使用，不得用于人体。 |
| 纯度: | 95%、98% |
| 盐体系: | 可选TFA、HAc、HCl或其它 |
| 生成周期: | 2-3周 |
| 储存条件: | 负80℃至负20℃ |
| 标签: | 强啡肽(Dynorphin) |
Truncation of the last six amino acids in Dynorphin A leads to this undecapeptide which exhibited nearly the same selectivity and activity compared to the parent compound. Therefore, Dyn A (1-11)-amide has been widely used for structure-activity studies. Its binding affinities for K, µ and δ opioid receptors are 0.074 nM, 7.6 nM and 2.9 nM, respectively.
Definition
Dynorphins are a class of endogenous opioid peptides produced in many different parts of the brain, including the hypothalamus, the hippocampus and the spinal cord, and have many different physiological actions, depending upon the site of production.
Related peptides
Dynorphins arise from the precursor protein prodynorphin. When prodynorphin is cleaved during processing by proprotein convertase 2 (PC2), multiple active peptides are released: dynorphin A, dynorphin B, “big dynorphin” and a/ß-neo-endorphin1.
Discovery
Dynophin was discovered in the mid 1970's in the laboratory of Avram Goldstein, one of the most important researchers in the field of opioid receptors and endogenous opioid peptides. The molecular identification was achieved by Goldstein in collaboration with the Japanese biochemist, Shinro Tachibana for purification, and M. Hunkapiller and L. Hood, who performed the microsequencing.
Structural characteristics
A 4,000-dalton dynorphin (also called the “Big dynorphin”) was isolated from porcine pituitary. It has 32 amino acids, with a heptadecapeptide (17 amino acid sequence), called dynorphin A, at its amino terminus and a related tridecapeptide (13 amino acid sequence), dynorphin B, at its carboxyl terminus. The two peptides are separated by the "processing signal" Lys-Arg2.
Mechanism of action
Dynorphins primarily exert their effects through a G-protein coupled receptor called the ?-opioid receptor (KOR) 3. Although KOR is the primary receptor for all dynorphins, the peptides do have some affinity for the µ-opioid receptor (MOR), d-opioid receptor (DOR), N-methyl-D-aspartic acid (NMDA)-type glutamate receptor, and bradykinin receptor. Different dynorphins show different receptor selectivities and potencies at receptors. Both big dynorphin and dynorphin A are more potent and more selective than dynorphin B. Dynorphin decreases dopamine release by binding to KORs on dopamine nerve terminals, which leads to drug tolerance and withdrawal symptoms.
Functions
Dynorphins modulate pain response. They can significantly inhibit morphine- or beta-endorphin-induced analgesia4. Dynorphins inhibit dopamine release that would counter the pleasurable effects of cocaine5. They are important in maintaining homeostasis through appetite control and circadian rhythms6. In addition to their role in weight control, dynorphins have also been found to regulate body temperature7.
References
1. Day, R., Lazure, C., Basak, A., Boudreault, A., Limperis, P., Dong, W., et al. (1998). Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J Biol. Chem., 273(2), 829-836.
2. W Fischli, A Goldstein, M W Hunkapiller, and L E Hood (1982). Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary. PNAS, 79 (17), 5435-5437.
3. Nyberg, F. & Hallburg, M. (2007). Neuropeptides in hyperthermia. Progress in brain research, 162:277-93.
4. FC Tulunay, MF Jen, JK Chang, HH Loh and NM Lee, (1981). Possible regulatory role of dynorphin on morphine- and beta-endorphin- induced analgesia. American Society for Pharmacology and Experimental Therapeutics, 219 (2), 296-298.
5. Clavin, W. (2005). Dynorphin: Nature’s Own Antidote to Cocaine (and Pleasure?).
6. Przewlocki, R., Lason, W., Konecka, A. M., Gramsch, C., Herz, A., & Reid, L. D. (1983). The opioid peptide dynorphin, circadian rhythms, and starvation. Science, 219(4580), 71-73.
7. Xin, L., Geller, E. B., & Adler, M. W. (1997). Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain. Journal of Pharmacology and Experimental Therapeutics, 281(1), 499-507.
| DOI | 名称 | |
|---|---|---|
| 10.1021/jm00049a010 | Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11 | 下载 |
| 10.1021/jm960747t | Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution | 下载 |
多肽H2N-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-NH2的合成步骤：
1、合成MBHA树脂：取若干克的MBHA树脂（如初始取代度为0.5mmol/g）和1倍树脂摩尔量的Fmoc-Linker-OH加入到反应器中，加入DMF，搅拌使氨基酸完全溶解。再加入树脂2倍量的DIEPA，搅拌混合均匀。再加入树脂0.95倍量的HBTU，搅拌混合均匀。反应3-4小时后，用DMF洗涤3次。用2倍树脂体积的10%乙酸酐/DMF 进行封端30分钟。然后再用DMF洗涤3次，甲醇洗涤2次，DCM洗涤2次，再用甲醇洗涤2次。真空干燥12小时以上，得到干燥的树脂{Fmoc-Linker-MHBA Resin}，测定取代度。这里测得取代度为 0.3mmol/g。结构如下图：
2、脱Fmoc：取1.48g的上述树脂，用DCM或DMF溶胀20分钟。用DMF洗涤2遍。加3倍树脂体积的20%Pip/DMF溶液，鼓氮气30分钟，然后2倍树脂体积的DMF 洗涤5次。得到 H2N-Linker-MBHA Resin 。（此步骤脱除Fmoc基团，茚三酮检测为蓝色，Pip为哌啶）。结构图如下：
3、缩合：取1.33mmol Fmoc-Lys(Boc)-OH 氨基酸，加入到上述树脂里，加适当DMF溶解氨基酸，再依次加入2.66mmol DIPEA，1.27mmol HBTU。反应30分钟后，取小样洗涤，茚三酮检测为无色。用2倍树脂体积的DMF 洗涤3次树脂。（洗涤树脂，去掉残留溶剂，为下一步反应做准备）。得到Fmoc-Lys(Boc)-Linker-MBHA Resin。氨基酸：DIPEA：HBTU：树脂=3：6：2.85：1（摩尔比）。结构图如下：
4、依次循环步骤二、步骤三，依次得到
H2N-Lys(Boc)-Linker-MBHA Resin
Fmoc-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Gly-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Gly-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Gly-Gly-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
H2N-Gly-Gly-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
Fmoc-Tyr(tBu)-Gly-Gly-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin
以上中间结构，均可在专肽生物多肽计算器-多肽结构计算器中，一键画出。
最后再经过步骤二得到 H2N-Tyr(tBu)-Gly-Gly-Phe-Leu-Arg(Pbf)-Arg(Pbf)-Ile-Arg(Pbf)-Pro-Lys(Boc)-Linker-MBHA Resin，结构如下：
5、切割：6倍树脂体积的切割液（或每1g树脂加8ml左右的切割液），摇床摇晃 2小时，过滤掉树脂，用冰无水乙醚沉淀滤液，并用冰无水乙醚洗涤沉淀物3次，最后将沉淀物放真空干燥釜中，常温干燥24小试，得到粗品H2N-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-NH2。结构图见产品结构图。
切割液选择：1）TFA：H2O=95%：5%
2）TFA：H2O：TIS=95%：2.5%：2.5%
3）三氟乙酸：茴香硫醚：1，2-乙二硫醇：苯酚：水=87.5%：5%：2.5%：2.5%：2.5%
（前两种适合没有容易氧化的氨基酸，例如Trp、Cys、Met。第三种适合几乎所有的序列。）
6、纯化冻干：使用液相色谱纯化，收集目标峰液体，进行冻干，获得蓬松的粉末状固体多肽。不过这时要取小样复测下纯度 是否目标纯度。
7、最后总结：
杭州专肽生物技术有限公司（ALLPEPTIDE https://www.allpeptide.com）主营定制多肽合成业务，提供各类长肽，短肽，环肽，提供各类修饰肽，如：荧光标记修饰（CY3、CY5、CY5.5、CY7、FAM、FITC、Rhodamine B、TAMRA等），功能基团修饰肽（叠氮、炔基、DBCO、DOTA、NOTA等），同位素标记肽（N15、C13），订书肽（Stapled Peptide）,脂肪酸修饰肽（Pal、Myr、Ste），磷酸化修饰肽（P-Ser、P-Thr、P-Tyr），环肽（酰胺键环肽、一对或者多对二硫键环），生物素标记肽，PEG修饰肽，甲基化修饰肽等。
以上所有内容，为专肽生物原创内容，请勿发布到其他网站上。
